The global Sexual Health Market Growth Accelerated by Increasing Awareness on Protection

 

Sexual health refers to the ability of people to experience and integrate their physical, emotional, mental and social well-being related to sexuality. Sexual health products such as condoms, creams, foams, gels, female condoms, lubricants, pregnancy testing kits, and sex toys are utilized to protect sexual health in people. These products provide comfort and pleasure during intimate relationships and are also effective ways to prevent sexually transmitted diseases and unintended pregnancies.

The global Sexual Health Market is estimated to be valued at US$ 32.15 Mn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increasing awareness about the importance of protection during intimacy through education programs by the government and non-profit organizations has been a key driver for the Sexual Health Market. People across generations are now more aware and informed about the benefits of practicing protected sex and using contraceptives. This has led to higher sales of condoms, lubricants and other sexual wellness products over the past few years. Sex educational initiatives in schools and communities have contributed significantly towards normalization of discussing sexuality openly and reducing the social stigma around buying and using sexual health products. The growing acceptance and willingness to learn about self-pleasure safely is expected to further fuel the demand for these items during the forecast period.

Segment Analysis
Sexual health market is broadly segmented into contraceptives, sexual lubricants, OTC drugs, condoms, and other products. The contraceptive segment currently dominates the market. In the contraceptives segment, birth control pills is the largest sub-segment due to high adoption among married women for planned parenthood.

Key Takeaways
The global sexual health market is expected to witness high growth. The market size is projected to grow from US$ 32.15 Mn in 2023 to US$ 52.35 Mn by 2030, register ing a CAGR of 7.1% during the forecast period.

Regional analysis:
North America region currently dominates the market due rising awareness level regarding sexual health, safe sex practices and rising prevalence of sexually transmitted infections. However, Asia Pacific region is expected to witness fastest growth over forecast period owing to large population base, rapid urbanization and improving healthcare infrastructure in the region.

Key players:
Key players operating in the sexual health market are Bayer AG, Pfizer Inc., and Eli Lilly and Company. Bayer AG holds leading market share in contraceptives segment. Pfizer Inc. offers wide range of products covering erectile dysfunction, contraceptives and vaginal health. Eli Lilly and Company specializes in erectile dysfunction drugs

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more